Effect of Virological Response to Entecavir on the Development of Hepatocellular Carcinoma in Hepatitis B Viral Cirrhotic Patients: Comparison Between Compensated and Decompensated Cirrhosis

EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

(2015)   JOURNAL OF HEPATOLOGY

Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B

(2013) A. K. Singal et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis

(2013) Grace Lai-Hung Wong et al.   HEPATOLOGY

Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutants

(2013) S.-C. Yang et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Predictive Scores for Hepatocellular Carcinoma Development in Chronic Hepatitis B Virus Infection: “Does One Size Fit All?”

(2012) Shiv K. Sarin et al.   GASTROENTEROLOGY

Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis

(2012) Roeland Zoutendijk et al.   GUT

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

(2012) Tetsuya Hosaka et al.   HEPATOLOGY

Hepatitis B virus-related decompensated liver cirrhosis: Benefits of antiviral therapy

(2012) Cheng-Yuan Peng et al.   JOURNAL OF HEPATOLOGY

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

(2012) Patrick Marcellin et al.   LANCET

Changes in serum histologic surrogate markers and procollagen III N-terminal peptide as independent predictors of HBeAg loss in patients with chronic hepatitis B during entecavir therapy

(2011) Jee Hoon Koo et al.   CLINICAL BIOCHEMISTRY

Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study

(2011) G. V. Papatheodoridis et al.   GUT

Management of hepatocellular carcinoma: An update

(2011) Jordi Bruix et al.   HEPATOLOGY

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B

(2010) Ting-Tsung Chang et al.   HEPATOLOGY

Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan)

(2010) Kyu Sik Jung et al.   HEPATOLOGY

Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers

(2010) Vincent Wai-Sun Wong et al.   JOURNAL OF CLINICAL ONCOLOGY

Risk assessment for the development of hepatocellular carcinoma: According to on-treatment viral response during long-term lamivudine therapy in hepatitis B virus-related liver disease

(2010) Jong Ryul Eun et al.   JOURNAL OF HEPATOLOGY

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review

(2010) George V. Papatheodoridis et al.   JOURNAL OF HEPATOLOGY

Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma

(2008) J. J. Y. SUNG et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B

(2008) Man-Fung Yuen et al.   JOURNAL OF HEPATOLOGY

Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors

(2007) Giovanna Fattovich et al.   JOURNAL OF HEPATOLOGY